FinTrust Capital Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,561
| Closed | -$83K | – | 1253 |
|
|
2022
Q3 | $83K | Hold |
1,561
| – | – | 0.02% | 409 |
|
|
2022
Q2 | $91K | Sell |
1,561
-757
| -33% | -$44.1K | 0.02% | 411 |
|
|
2022
Q1 | $176K | Buy |
2,318
+1,925
| +490% | +$146K | 0.04% | 305 |
|
|
2021
Q4 | $24K | Hold |
393
| – | – | 0.01% | 693 |
|
|
2021
Q3 | $22K | Sell |
393
-500
| -56% | -$28K | 0.01% | 718 |
|
|
2021
Q2 | $54K | Sell |
893
-3,200
| -78% | -$194K | 0.01% | 535 |
|
|
2021
Q1 | $287K | Buy |
4,093
+3,578
| +695% | +$251K | 0.08% | 208 |
|
|
2020
Q4 | $31K | Sell |
515
-160
| -24% | -$9.63K | 0.01% | 569 |
|
|
2020
Q3 | $41 | Sell |
675
-812
| -55% | -$49 | 0.01% | 525 |
|
|
2020
Q2 | $78K | Buy |
1,487
+752
| +102% | +$39.4K | 0.03% | 386 |
|
|
2020
Q1 | $25K | Hold |
735
| – | – | 0.01% | 578 |
|
|
2019
Q4 | $33K | Hold |
735
| – | – | 0.01% | 524 |
|
|
2019
Q3 | $28K | Buy |
735
+124
| +20% | +$4.72K | 0.01% | 553 |
|
|
2019
Q2 | $27K | Hold |
611
| – | – | 0.01% | 533 |
|
|
2019
Q1 | $23K | Buy |
+611
| New | +$23K | 0.01% | 565 |
|